Primary tumor location predicts poor clinical outcome with cetuximab in RAS wild-type metastatic colorectal cancer

Primary tumor location predicts poor clinical outcome with cetuximab in RAS wild-type metastatic colorectal cancer

Abstract Background In metastatic colorectal cancer, the location of the primary tumor has been suggested to have biological significance. In this study, we investigated whether primary tumor location affects cetuximab efficacy in patients with RAS wild-type metastatic colorectal cancer. Methods Gen...

Full description

Bibliographic Details
Main Authors: Dalyong Kim, Sun Young Kim, Ji Sung Lee, Yong Sang Hong, Jeong Eun Kim, Kyu-pyo Kim, Jihun Kim, Se Jin Jang, Young-Kwang Yoon, Tae Won Kim
Format: Article
Language:English
Published: BMC 2017-11-01
Series:BMC Gastroenterology
Subjects:
Primary tumor location
Metastatic colorectal cancer
Cetuximab
RAS wild-type
EGFR
Online Access:http://link.springer.com/article/10.1186/s12876-017-0694-6

Internet

http://link.springer.com/article/10.1186/s12876-017-0694-6

Similar Items